CJC No DAC / Ipamorelin

CJC No DAC / Ipamorelin combines two research peptides that study the growth-hormone system in different ways. CJC No DAC works through the GHRH pathway, while Ipamorelin works through the ghrelin/GHS receptor pathway. Both signals can affect how the pituitary releases growth hormone. Researchers study the combination to see how two separate signals can work together around growth-hormone pulses and IGF-1. The words "No DAC" matter because they identify the shorter-acting CJC-style version rather than the longer-lasting DAC form. This makes the blend especially useful in research focused on growth-hormone signaling and timing.